NEXTGENPCR Endpoint Thermocycler Decreases PCR Amplification Time for SARS-CoV-2 to Eight Minutes
Molecular Biology Systems, B.V. (Goes, The Netherlands), a biotechnology company, has developed a method using its NEXTGENPCR endpoint thermocycler and consumables that decreases PCR amplification time for SARS-CoV-2 to eight minutes. More...06 Apr 2020
ThermoGenesis Develops Blood Test to Detect COVID-19 in Minutes
ThermoGenesis Holdings, Inc. (Rancho Cordova, CA, USA), which provides automated cell processing tools and services in the cell and gene therapy field, has developed an advanced point-of-care test that will allow rapid diagnosis of the COVID-19 virus, including asymptomatic cases, using just a single drop of blood without the need for special lab equipment and deliver results in less than 10 minutes. More...06 Apr 2020
BIOTECON Expedites Launch of Viral RNA Extraction Kit for Detecting COVID-19
BIOTECON Diagnostics GmbH (Potsdam, Germany) has launched its newly-developed foodproof Magnetic Preparation Kit VI, which enables lab specialists to perform rapid, sensitive, and reliable RNA and DNA extraction from an array of different viruses. More...06 Apr 2020
Deep Throat SARS-CoV-2 Viral Load Ascertained in Saliva Samples
Posterior oropharyngeal saliva samples are a non-invasive specimen more acceptable to patients and health-care workers. Unlike severe acute respiratory syndrome, patients with COVID-19 had the highest viral load near presentation, which could account for the fast-spreading nature of this epidemic. More...06 Apr 2020
Mount Sinai Developing `End-to-End` Diagnostics Solution for COVID-19
Researchers and clinicians in microbiology, virology, pathology, molecular science, and immunology at the Icahn School of Medicine at Mount Sinai {(ISMMS) New York, NY, USA) and The Mount Sinai Hospital {(MSH) New York, NY, USA) are working on designing, validating, and implementing an “end-to-end” clinical pathology laboratory solution that will allow for the COVID-19 testing of approximately several hundred people per day in order to rapidly diagnose and help guide the selection of treatment and monitor disease course. More...04 Apr 2020
Vela Diagnostics to Offer Manual ViroKey SARS-CoV-2 RT-PCR Test
Vela Diagnostics (Singapore) plans to offer its manual ViroKey SARS-CoV-2 RT-PCR Test after its validation is completed and is currently working with the US Food and Drug Administration (FDA) for securing Emergency Use Authorization (EUA) for the test. More...04 Apr 2020
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Human Insulin CLIA
Human Insulin CLIA Kit
New
PSA Test
Human Semen Rapid Test
In Other News
Cellink Relaunches Real-Time qPCR Instrument for COVID-19
Novacyt's Two-Hour Coronavirus Test Gains FDA Emergency Use Approval
Ortho Clinical Diagnostics Releases COVID-19 Antibody Test
Chembio Launches DPP COVID-19 Serological Point-of-Care Test
A. Menarini and Credo Diagnostics Enter into Agreement for Distribution of SARS-CoV-2 Assay Kit
NeuMoDx Secures FDA Emergency Use Authorization for Coronavirus Test
World’s First Online Image-Based COVID-19 Diagnosis Improvement Tool Launched
Siemens Healthineers Announces Availability of Molecular Fast Track Diagnostics SARS-CoV-2 Assay Test Kit
DiaSorin’s COVID-19 Test Receives FDA Emergency Use Authorization
QIAGEN Receives US FDA EUA for First and Only Syndromic Coronavirus Test
Carolina Liquid Chemistries Offers COVID-19 Rapid Screen Antibody Test
Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test
Beckman Coulter Developing Tests to Detect Coronavirus Antibodies
Siemens' RAPIDPoint 500e Blood Gas Analyzer Receives US FDA Clearance to Aid in COVID-19 Care
Quidel’s Lyra SARS-CoV-2 Secures Expanded Use Authorization from US FDA
Hardy Diagnostics Releases Autobio’s One-Step Test for COVID-19
University of Oxford Develops Rapid Testing Technology for Coronavirus; Starts Clinical Trial of Potential Drug Treatments
New Paper-Based Rapid Test for COVID-19 Awaiting FDA EUA Approval
Chembio and LumiraDx Enter into COVID-19 Strategic Partnership
PerkinElmer’s New Nucleic Acid Detection Kit for SARS-CoV-2 Secures FDA EUA Approval
Luminex Receives US FDA Emergency Use Authorization for COVID-19 Virus Detection Test
The COVID-19 Coronavirus Remains Viable for Hours or Days on Solid Surfaces
Factors Associated with ARDS in COVID-19 Identified
